What Actuaries Need to Know About Emerging Therapies
- 1 minute reading time
As cell and gene therapies evolve, actuaries must adapt models to account for evolving regulations, uncertain clinical outcomes, and changing financial frameworks.
Continue reading with a PwC Plus-Subscription
- verified Information source
- daily updates
- completely searchable articles (with refiner)
- tailored alert